Table 4 Overall performance of patients treated with sequential boost and integrated boost at 4 years
4 year follow up | Sequential boost | Integrated boost |
|---|---|---|
Overall survival | 69.3% (56.5–79) | 76.8% (68.6–83.1) |
Disease Free Survival | 63% (50.4–73.3) | 69% (60.4–76.1) |
Local recurrence-free survival | 88.2% (76.7–94.2) | 85.9% (78.2–91) |
Regional recurrence-free survival | 92.1% (82.1–96.7) | 91.6% (84.8–95.4) |
Distant disease-free survival | 89.9% (78.8–95.4) | 88.9% (82–93.3) |